Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response-Reference-Cited by-同舟云学术

Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response

Published:1992-07 Issue:2 Volume:33 Page:127-134
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Isacson Rut,Kedar Eli,Barak Vivian,Gazit Zulma,Yurim Oded,Kalichman Inna,Ben-Bassat Hannah,Biran Shoshana,Schlesinger Michael,Franks Christopher R.,Roest Gerda J.,Palmer Peter A.,Shiloni Eitan

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference37 articles.

1. Cutaneous Melanoma

2. Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

3. Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma

4. Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination;OncoImmunology;2017-06-16

2. Efficacy and safety of bio-chemotherapy with dacarbazine plus interleukin-2 in patients with unresectable malignant melanoma;Asia-Pacific Journal of Clinical Oncology;2015-08-26

3. State of Melanoma;Hematology/Oncology Clinics of North America;2014-06

4. Chemotherapy and biologic therapies for melanoma: do they work?;Clinics in Dermatology;2009-11

5. Aldesleukin (Recombinant Interleukin-2);BioDrugs;1997-05